Report Detail
COVID-19 Impact on Global Bio Similars/Subsequent Entry Biologic Market Size, Status and Forecast 2020-2026
- RnM3987519 |
- 04 June, 2020 |
- Global |
- 158 Pages |
- QYResearch |
- Other
This report focuses on the global Bio Similars/Subsequent Entry Biologic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bio Similars/Subsequent Entry Biologic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Sun Pharma
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck
Biogen idec
Genentech (Roche)
Pfizer
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG
AbbVie
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
3sbio
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Market segment by Type, the product can be split into
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Market segment by Application, split into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Bio Similars/Subsequent Entry Biologic status, future forecast, growth opportunity, key market and key players.
To present the Bio Similars/Subsequent Entry Biologic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Bio Similars/Subsequent Entry Biologic are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Bio Similars/Subsequent Entry Biologic Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Monoclonal Antibodies
- 1.4.3 Interferon
- 1.4.4 Erythropoietin
- 1.4.5 Insulin
- 1.4.6 Vaccines
- 1.4.7 Other
- 1.5 Market by Application
- 1.5.1 Global Bio Similars/Subsequent Entry Biologic Market Share by Application: 2020 VS 2026
- 1.5.2 Tumor
- 1.5.3 Diabetes
- 1.5.4 Cardiovascular
- 1.5.5 Hemophilia
- 1.5.6 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Bio Similars/Subsequent Entry Biologic Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Bio Similars/Subsequent Entry Biologic Industry
- 1.6.1.1 Bio Similars/Subsequent Entry Biologic Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Bio Similars/Subsequent Entry Biologic Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Bio Similars/Subsequent Entry Biologic Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Bio Similars/Subsequent Entry Biologic Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Bio Similars/Subsequent Entry Biologic Market Perspective (2015-2026)
- 2.2 Bio Similars/Subsequent Entry Biologic Growth Trends by Regions
- 2.2.1 Bio Similars/Subsequent Entry Biologic Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Bio Similars/Subsequent Entry Biologic Historic Market Share by Regions (2015-2020)
- 2.2.3 Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Bio Similars/Subsequent Entry Biologic Market Growth Strategy
- 2.3.6 Primary Interviews with Key Bio Similars/Subsequent Entry Biologic Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Bio Similars/Subsequent Entry Biologic Players by Market Size
- 3.1.1 Global Top Bio Similars/Subsequent Entry Biologic Players by Revenue (2015-2020)
- 3.1.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Bio Similars/Subsequent Entry Biologic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Bio Similars/Subsequent Entry Biologic Market Concentration Ratio
- 3.2.1 Global Bio Similars/Subsequent Entry Biologic Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Bio Similars/Subsequent Entry Biologic Revenue in 2019
- 3.3 Bio Similars/Subsequent Entry Biologic Key Players Head office and Area Served
- 3.4 Key Players Bio Similars/Subsequent Entry Biologic Product Solution and Service
- 3.5 Date of Enter into Bio Similars/Subsequent Entry Biologic Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Bio Similars/Subsequent Entry Biologic Historic Market Size by Type (2015-2020)
- 4.2 Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Type (2021-2026)
5 Bio Similars/Subsequent Entry Biologic Breakdown Data by Application (2015-2026)
- 5.1 Global Bio Similars/Subsequent Entry Biologic Market Size by Application (2015-2020)
- 5.2 Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Bio Similars/Subsequent Entry Biologic Market Size (2015-2020)
- 6.2 Bio Similars/Subsequent Entry Biologic Key Players in North America (2019-2020)
- 6.3 North America Bio Similars/Subsequent Entry Biologic Market Size by Type (2015-2020)
- 6.4 North America Bio Similars/Subsequent Entry Biologic Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Bio Similars/Subsequent Entry Biologic Market Size (2015-2020)
- 7.2 Bio Similars/Subsequent Entry Biologic Key Players in Europe (2019-2020)
- 7.3 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2015-2020)
- 7.4 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2015-2020)
8 China
- 8.1 China Bio Similars/Subsequent Entry Biologic Market Size (2015-2020)
- 8.2 Bio Similars/Subsequent Entry Biologic Key Players in China (2019-2020)
- 8.3 China Bio Similars/Subsequent Entry Biologic Market Size by Type (2015-2020)
- 8.4 China Bio Similars/Subsequent Entry Biologic Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Bio Similars/Subsequent Entry Biologic Market Size (2015-2020)
- 9.2 Bio Similars/Subsequent Entry Biologic Key Players in Japan (2019-2020)
- 9.3 Japan Bio Similars/Subsequent Entry Biologic Market Size by Type (2015-2020)
- 9.4 Japan Bio Similars/Subsequent Entry Biologic Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size (2015-2020)
- 10.2 Bio Similars/Subsequent Entry Biologic Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size by Type (2015-2020)
- 10.4 Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size by Application (2015-2020)
11 India
- 11.1 India Bio Similars/Subsequent Entry Biologic Market Size (2015-2020)
- 11.2 Bio Similars/Subsequent Entry Biologic Key Players in India (2019-2020)
- 11.3 India Bio Similars/Subsequent Entry Biologic Market Size by Type (2015-2020)
- 11.4 India Bio Similars/Subsequent Entry Biologic Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Bio Similars/Subsequent Entry Biologic Market Size (2015-2020)
- 12.2 Bio Similars/Subsequent Entry Biologic Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Bio Similars/Subsequent Entry Biologic Market Size by Type (2015-2020)
- 12.4 Central & South America Bio Similars/Subsequent Entry Biologic Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Sun Pharma
- 13.1.1 Sun Pharma Company Details
- 13.1.2 Sun Pharma Business Overview and Its Total Revenue
- 13.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Introduction
- 13.1.4 Sun Pharma Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020))
- 13.1.5 Sun Pharma Recent Development
- 13.2 Synthon Pharmaceuticals
- 13.2.1 Synthon Pharmaceuticals Company Details
- 13.2.2 Synthon Pharmaceuticals Business Overview and Its Total Revenue
- 13.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Introduction
- 13.2.4 Synthon Pharmaceuticals Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 13.2.5 Synthon Pharmaceuticals Recent Development
- 13.3 Teva Pharmaceutical Industries
- 13.3.1 Teva Pharmaceutical Industries Company Details
- 13.3.2 Teva Pharmaceutical Industries Business Overview and Its Total Revenue
- 13.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Introduction
- 13.3.4 Teva Pharmaceutical Industries Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 13.3.5 Teva Pharmaceutical Industries Recent Development
- 13.4 LG Life Sciences
- 13.4.1 LG Life Sciences Company Details
- 13.4.2 LG Life Sciences Business Overview and Its Total Revenue
- 13.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Introduction
- 13.4.4 LG Life Sciences Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 13.4.5 LG Life Sciences Recent Development
- 13.5 Celltrion Biocon
- 13.5.1 Celltrion Biocon Company Details
- 13.5.2 Celltrion Biocon Business Overview and Its Total Revenue
- 13.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Introduction
- 13.5.4 Celltrion Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 13.5.5 Celltrion Biocon Recent Development
- 13.6 Hospira
- 13.6.1 Hospira Company Details
- 13.6.2 Hospira Business Overview and Its Total Revenue
- 13.6.3 Hospira Bio Similars/Subsequent Entry Biologic Introduction
- 13.6.4 Hospira Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 13.6.5 Hospira Recent Development
- 13.7 Merck
- 13.7.1 Merck Company Details
- 13.7.2 Merck Business Overview and Its Total Revenue
- 13.7.3 Merck Bio Similars/Subsequent Entry Biologic Introduction
- 13.7.4 Merck Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 13.7.5 Merck Recent Development
- 13.8 Biogen idec
- 13.8.1 Biogen idec Company Details
- 13.8.2 Biogen idec Business Overview and Its Total Revenue
- 13.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Introduction
- 13.8.4 Biogen idec Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 13.8.5 Biogen idec Recent Development
- 13.9 Genentech (Roche)
- 13.9.1 Genentech (Roche) Company Details
- 13.9.2 Genentech (Roche) Business Overview and Its Total Revenue
- 13.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Introduction
- 13.9.4 Genentech (Roche) Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 13.9.5 Genentech (Roche) Recent Development
- 13.10 Pfizer
- 13.10.1 Pfizer Company Details
- 13.10.2 Pfizer Business Overview and Its Total Revenue
- 13.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Introduction
- 13.10.4 Pfizer Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 13.10.5 Pfizer Recent Development
- 13.11 Celltrion
- 10.11.1 Celltrion Company Details
- 10.11.2 Celltrion Business Overview and Its Total Revenue
- 10.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Introduction
- 10.11.4 Celltrion Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.11.5 Celltrion Recent Development
- 13.12 Biocon
- 10.12.1 Biocon Company Details
- 10.12.2 Biocon Business Overview and Its Total Revenue
- 10.12.3 Biocon Bio Similars/Subsequent Entry Biologic Introduction
- 10.12.4 Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.12.5 Biocon Recent Development
- 13.13 Amgen
- 10.13.1 Amgen Company Details
- 10.13.2 Amgen Business Overview and Its Total Revenue
- 10.13.3 Amgen Bio Similars/Subsequent Entry Biologic Introduction
- 10.13.4 Amgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.13.5 Amgen Recent Development
- 13.14 Samsung Biologics
- 10.14.1 Samsung Biologics Company Details
- 10.14.2 Samsung Biologics Business Overview and Its Total Revenue
- 10.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Introduction
- 10.14.4 Samsung Biologics Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.14.5 Samsung Biologics Recent Development
- 13.15 Mylan
- 10.15.1 Mylan Company Details
- 10.15.2 Mylan Business Overview and Its Total Revenue
- 10.15.3 Mylan Bio Similars/Subsequent Entry Biologic Introduction
- 10.15.4 Mylan Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.15.5 Mylan Recent Development
- 13.16 Dr. Reddy's Laboratories
- 10.16.1 Dr. Reddy's Laboratories Company Details
- 10.16.2 Dr. Reddy's Laboratories Business Overview and Its Total Revenue
- 10.16.3 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Introduction
- 10.16.4 Dr. Reddy's Laboratories Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.16.5 Dr. Reddy's Laboratories Recent Development
- 13.17 Stada Arzneimittel AG
- 10.17.1 Stada Arzneimittel AG Company Details
- 10.17.2 Stada Arzneimittel AG Business Overview and Its Total Revenue
- 10.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Introduction
- 10.17.4 Stada Arzneimittel AG Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.17.5 Stada Arzneimittel AG Recent Development
- 13.18 AbbVie
- 10.18.1 AbbVie Company Details
- 10.18.2 AbbVie Business Overview and Its Total Revenue
- 10.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Introduction
- 10.18.4 AbbVie Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.18.5 AbbVie Recent Development
- 13.19 Sanofi-Aventis
- 10.19.1 Sanofi-Aventis Company Details
- 10.19.2 Sanofi-Aventis Business Overview and Its Total Revenue
- 10.19.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Introduction
- 10.19.4 Sanofi-Aventis Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.19.5 Sanofi-Aventis Recent Development
- 13.20 Johnson & Johnson
- 10.20.1 Johnson & Johnson Company Details
- 10.20.2 Johnson & Johnson Business Overview and Its Total Revenue
- 10.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Introduction
- 10.20.4 Johnson & Johnson Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.20.5 Johnson & Johnson Recent Development
- 13.21 Novo Nordisk
- 10.21.1 Novo Nordisk Company Details
- 10.21.2 Novo Nordisk Business Overview and Its Total Revenue
- 10.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Introduction
- 10.21.4 Novo Nordisk Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.21.5 Novo Nordisk Recent Development
- 13.22 Eli Lilly
- 10.22.1 Eli Lilly Company Details
- 10.22.2 Eli Lilly Business Overview and Its Total Revenue
- 10.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Introduction
- 10.22.4 Eli Lilly Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.22.5 Eli Lilly Recent Development
- 13.23 Novartis
- 10.23.1 Novartis Company Details
- 10.23.2 Novartis Business Overview and Its Total Revenue
- 10.23.3 Novartis Bio Similars/Subsequent Entry Biologic Introduction
- 10.23.4 Novartis Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.23.5 Novartis Recent Development
- 13.24 3sbio
- 10.24.1 3sbio Company Details
- 10.24.2 3sbio Business Overview and Its Total Revenue
- 10.24.3 3sbio Bio Similars/Subsequent Entry Biologic Introduction
- 10.24.4 3sbio Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.24.5 3sbio Recent Development
- 13.25 Biotech
- 10.25.1 Biotech Company Details
- 10.25.2 Biotech Business Overview and Its Total Revenue
- 10.25.3 Biotech Bio Similars/Subsequent Entry Biologic Introduction
- 10.25.4 Biotech Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.25.5 Biotech Recent Development
- 13.26 Gelgen
- 10.26.1 Gelgen Company Details
- 10.26.2 Gelgen Business Overview and Its Total Revenue
- 10.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Introduction
- 10.26.4 Gelgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.26.5 Gelgen Recent Development
- 13.27 Innovent
- 10.27.1 Innovent Company Details
- 10.27.2 Innovent Business Overview and Its Total Revenue
- 10.27.3 Innovent Bio Similars/Subsequent Entry Biologic Introduction
- 10.27.4 Innovent Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.27.5 Innovent Recent Development
- 13.28 Dong Bao
- 10.28.1 Dong Bao Company Details
- 10.28.2 Dong Bao Business Overview and Its Total Revenue
- 10.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Introduction
- 10.28.4 Dong Bao Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.28.5 Dong Bao Recent Development
- 13.29 Ganlee
- 10.29.1 Ganlee Company Details
- 10.29.2 Ganlee Business Overview and Its Total Revenue
- 10.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Introduction
- 10.29.4 Ganlee Revenue in Bio Similars/Subsequent Entry Biologic Business (2015-2020)
- 10.29.5 Ganlee Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Bio Similars/Subsequent Entry Biologic. Industry analysis & Market Report on COVID-19 Impact on Global Bio Similars/Subsequent Entry Biologic is a syndicated market report, published as COVID-19 Impact on Global Bio Similars/Subsequent Entry Biologic Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Bio Similars/Subsequent Entry Biologic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
